Addressing Factors to Reduce Interruption of Continuous Glucose Monitor Use During Radiologic Procedures

Abstract

Get full access to this article

View all access options for this article.

References

American Diabetes Association Professional Practice Committee, et al. “7. Diabetes Technology: Standards of Care in Diabetes-2024.”. American Diabetes Association, American Diabetes Association, 11 Dec. 2023. Available from: https://diabetesjournals.org/care/article/47/Supplement_1/S126/153939/7-Diabetes-Technology-Standards-of-Care-in [Last accessed: August 5, 2024 ].

Aleppo

, Beck

, Bailey

, et al. Type 2 Diabetes Basal Insulin Users: The Mobile Study (MOBILE) Study Group. The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. Diabetes Care, 2021; 44(12):2729–2737; doi: 10.2337/dc21-1304

Markov

, Krutilova

, Cedeno

, et al. Interruption of CGM: Frequency and adverse consequences. J Diabetes Sci Technol, 2024; 18(5):1096–1101; doi: 10.1177/19322968231156572

Matievich

, Kiaie

, Dunn

. Safety and functional integrity of continuous glucose monitoring sensors when used during radiologic procedures under high exposure conditions. J Diabetes Sci Technol, 2023; 17(6):1634–1643; doi: 10.1177/19322968221106206

FDA 510(k). Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K233537 [Last accessed: August 12, 2024 ].